Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
暂无分享,去创建一个
Sebastian M. Armasu | Andrew D. Johnson | A. Reiner | J. Pankow | P. Ridker | D. Chasman | X. Jouven | E. Goode | D. Rader | B. Psaty | P. Kraft | D. Trégouët | C. Willer | K. Taylor | J. Brody | M. Germain | P. Morange | J. Hansen | R. Do | P. Natarajan | S. Braekkan | M. de Andrade | S. Damrauer | S. Heckbert | T. Bartz | F. Rosendaal | C. Kooperberg | R. Loos | K. Hveem | G. Cuéllar-Partida | Ming-Huei Chen | G. Nadkarni | R. Li-Gao | M. Teder-Laving | M. Andrade | A. Boland | J. Deleuze | P. Lutsey | N. Pankratz | J. Empana | Kaoru Ito | Wei Zhou | B. Brumpton | J. Huffman | H. M. Vy | B. Wolford | D. Klarin | R. Judy | M. Levin | J. Lynch | R. Kember | M. Sabater-Lleal | P. D. de Vries | J. Souto | J. Soria | N. Smith | K. Wiggins | R. Olaso | F. Thibord | P. Suchon | Constance Turman | A. Martinez-Perez | Xin Wang | N. Saut | S. Armasu | D. Smadja | D. Aïssi | C. Kabrhel | K. Hindberg | D. Ko | Traci M Bartz | Jennifer A. Brody | T. Nøst | Katharine R. Clapham | J. Haessler | J. Emmerich | Traci M. Bartz | V. Morelli | I. Komuro | W. Tang | S. Rich | J. Pattee | P. Morange | S. Koyama | A. Johnson | T. Gilliland | Franco Giulianini | J. Carlos Souto | C. O’Donnell | Kyung Min Lee | A. Johnson | R. Jackson | Corriene Sept | Jose Manuel Soria | A. Vlieg | Delphine Daian-Bacq | Anne Heidi Skogholt | K. Ito | H. Vy | B. Psaty | R. Loos | Christopher J. O'Donnell | N. Smith | Joseph Emmerich | K. Ito | A. Skogholt | Barbara McKnight | J. Lynch | Stephen S. Rich | Girish N. Nadkarni | X. Jouven | Alexander P. Reiner | Dylan Aïssi | Ellen L. Goode | Daian-Bacq | Kaoru Ito | Pradeep Natarajan MD MMSc | Jack W. Pattee | Li-Gao | MS MarineGermain | Darae Ko | 12 Thomas | Gilliland | Ron Do | Xin Wang | Wei Zhou | Jeffery Haessler | 14 Kristian | Hindberg | David M. Smadja | Katharine Clapham | J. F. Loos | P. Kraft | B. Psaty | Weihong Tang | John-Bjarne Hansen | C. Kabrhel | G. N. Nadkarni | David M Smadja | S. S. Rich
[1] E. Boerwinkle,et al. Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies , 2022, Nature Genetics.
[2] B. Neale,et al. Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases , 2022, medRxiv.
[3] S. Watson,et al. Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High Shear , 2022, International journal of molecular sciences.
[4] Wei Zhou,et al. Global Biobank Meta-analysis Initiative: powering genetic discovery across human diseases , 2021, medRxiv.
[5] J. Marchini,et al. Exome sequencing and analysis of 454,787 UK Biobank participants , 2021, Nature.
[6] B. Nordestgaard,et al. α1 -antitrypsin Z allele and risk of venous thromboembolism in the general population. , 2021, Journal of thrombosis and haemostasis : JTH.
[7] O. McCarty,et al. Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function. , 2021, American Journal of Physiology - Cell Physiology.
[8] G. Tamiya,et al. ALOX12 mutation in a family with dominantly inherited bleeding diathesis , 2021, Journal of Human Genetics.
[9] P. Morange,et al. Impaired adhesion of neutrophils expressing Slc44a2/HNA-3b to VWF protects against NETosis under venous shear rate. , 2021, Blood.
[10] Benjamin D. Heavner,et al. Genome sequencing unveils a regulatory landscape of platelet reactivity , 2019, Nature Communications.
[11] D. Garcia,et al. Does aspirin prevent venous thromboembolism? , 2020, Hematology. American Society of Hematology. Education Program.
[12] J. Weitz,et al. New anticoagulants: Moving beyond the direct oral anticoagulants , 2020, Journal of thrombosis and haemostasis : JTH.
[13] P. Wild,et al. Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism – results from clinical observation studies , 2020, EBioMedicine.
[14] Valeriia Haberland,et al. The MRC IEU OpenGWAS data infrastructure , 2020, bioRxiv.
[15] Ryan M Burke,et al. The choline transporter Slc44a2 controls platelet activation and thrombosis by regulating mitochondrial function , 2020, Nature Communications.
[16] A. Schultze,et al. Incidence and prevalence of venous thromboembolism in Norway 2010-2017. , 2020, Thrombosis research.
[17] Andrew D. Johnson,et al. A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling. , 2020, American journal of human genetics.
[18] P. Kraft,et al. Leveraging expression from multiple tissues using sparse canonical correlation analysis and aggregate tests improve the power of transcriptome-wide association studies , 2020, bioRxiv.
[19] D. Goldstein,et al. Whole exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease. , 2020, Blood.
[20] N. Mackman,et al. Therapeutic strategies for thrombosis: new targets and approaches , 2020, Nature Reviews Drug Discovery.
[21] Mitchell J. Machiela,et al. LDlinkR: An R Package for Rapidly Calculating Linkage Disequilibrium Statistics in Diverse Populations , 2020, Frontiers in Genetics.
[22] Reza Hajizadeh,et al. Prognostic value of platelet indices in patients with acute pulmonary thromboembolism , 2020, Journal of cardiovascular and thoracic research.
[23] William J. Astle,et al. Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations , 2020, Cell.
[24] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[25] Sebastian M. Armasu,et al. Genomic and Transcriptomic Association Studies Identify 16 Novel Susceptibility Loci for Venous Thromboembolism. , 2019, Blood.
[26] Yan V. Sun,et al. Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease , 2019, Nature Genetics.
[27] W. Nseir,et al. The role of neutrophil‐lymphocyte ratio, and mean platelet volume in detecting patients with acute venous thromboembolism , 2019, Journal of clinical laboratory analysis.
[28] Scott T. Weiss,et al. Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations , 2019, bioRxiv.
[29] P. Dakle,et al. Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice , 2019, Leukemia.
[30] D. Trégouët,et al. Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation , 2019, Scientific Reports.
[31] John D. Eicher,et al. A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology. , 2019, Blood.
[32] I. Hers,et al. Critical roles for the phosphatidylinositide 3-kinase isoforms p110β and p110γ in thrombopoietin-mediated priming of platelet function , 2019, Scientific Reports.
[33] Andrew D. Johnson,et al. Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels , 2019, Circulation.
[34] C. Farber,et al. RACER: A data visualization strategy for exploring multiple genetic associations , 2018, bioRxiv.
[35] W. Ouwehand,et al. High-throughput elucidation of thrombus formation reveals sources of platelet function variability , 2018, Haematologica.
[36] A. Perkins,et al. EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription , 2018, Nature Communications.
[37] J. Fontcuberta,et al. Short closure time values in PFA-100® are related to venous thrombotic risk. Results from the RETROVE Study. , 2018, Thrombosis Research.
[38] M. Frontini,et al. Activated αIIbβ3 on platelets mediates flow-dependent NETosis via SLC44A2 , 2018, bioRxiv.
[39] J. Staško,et al. Association of Genetic Variability in Selected Genes in Patients With Deep Vein Thrombosis and Platelet Hyperaggregability , 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[40] Stephen Burgess,et al. Genomic atlas of the human plasma proteome , 2018, Nature.
[41] L. Velazquez,et al. The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders , 2017, Leukemia.
[42] S. Kathiresan,et al. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor , 2017, Circulation. Cardiovascular genetics.
[43] A. Morris,et al. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease , 2017, PLoS genetics.
[44] R. Mägi,et al. Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panel , 2017, European Journal of Human Genetics.
[45] Andrew D. Johnson,et al. Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study. , 2017, Thrombosis research.
[46] Y. Kamatani,et al. Overview of the BioBank Japan Project: Study design and profile , 2017, Journal of epidemiology.
[47] A. Folsom,et al. Genome‐wide association study with additional genetic and post‐transcriptional analyses reveals novel regulators of plasma factor XI levels , 2017, Human molecular genetics.
[48] Luc Bressollette,et al. Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France , 2016, Thrombosis and Haemostasis.
[49] A. Brown,et al. Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis. , 2016, Human molecular genetics.
[50] Mary Brophy,et al. Million Veteran Program: A mega-biobank to study genetic influences on health and disease. , 2016, Journal of clinical epidemiology.
[51] D. MacArthur,et al. An eMERGE Clinical Center at Partners Personalized Medicine , 2016, Journal of personalized medicine.
[52] Lorna M. Lopez,et al. A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. , 2016, Human molecular genetics.
[53] T. Lehtimäki,et al. Integrative approaches for large-scale transcriptome-wide association studies , 2015, Nature Genetics.
[54] A. Kusiak. Department of Veterans Affairs Office of Research and Development's pain portfolio. , 2016, Journal of rehabilitation research and development.
[55] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[56] M. Hoffman. Coagulation in Liver Disease , 2015, Seminars in Thrombosis & Hemostasis.
[57] G. Kempermann. Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .
[58] Jun S. Liu,et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.
[59] K. Hao,et al. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. , 2015, American journal of human genetics.
[60] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[61] A. Metspalu,et al. An epidemiological perspective of personalized medicine: the Estonian experience , 2015, Journal of internal medicine.
[62] M. Daly,et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.
[63] M. Malumbres,et al. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. , 2015, Blood.
[64] H. Enomoto,et al. The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function , 2014, Nature.
[65] T. Lehtimäki,et al. Cardiovascular risk factors in 2011 and secular trends since 2007: The Cardiovascular Risk in Young Finns Study , 2014, Scandinavian journal of public health.
[66] Scott M. Williams,et al. Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2 , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[67] Zoltán Kutalik,et al. Quality control and conduct of genome-wide association meta-analyses , 2014, Nature Protocols.
[68] P. Sullivan,et al. Heritability and Genomics of Gene Expression in Peripheral Blood , 2014, Nature Genetics.
[69] C. Wallace,et al. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.
[70] Marylyn D. Ritchie,et al. Visualizing genomic information across chromosomes with PhenoGram , 2013, BioData Mining.
[71] Sebastian M. Armasu,et al. A Genome‐Wide Association Study for Venous Thromboembolism: The Extended Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium , 2013, Genetic epidemiology.
[72] Scott M. Williams,et al. Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. , 2012, Blood.
[73] Sebastian M. Armasu,et al. A genome‐wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q , 2012, Journal of thrombosis and haemostasis : JTH.
[74] Yoav Ben-Shlomo,et al. Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease. , 2012, American journal of human genetics.
[75] P. Ridker,et al. Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial , 2012, Circulation. Cardiovascular genetics.
[76] D. Trégouët,et al. Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project , 2012, British journal of haematology.
[77] P. Visscher,et al. A Better Coefficient of Determination for Genetic Profile Analysis , 2012, Genetic epidemiology.
[78] P. Visscher,et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.
[79] Daniel Bilbao,et al. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors , 2011, The EMBO journal.
[80] Tom Wilsgaard,et al. Cohort profile: The Tromsø Study , 2011, International journal of epidemiology.
[81] Jostein Holmen m.fl. The Nord-Trøndelag Health Study 1995-97 (HUNT 2) , 2011 .
[82] Mark I McCarthy,et al. Genomic inflation factors under polygenic inheritance , 2011, European Journal of Human Genetics.
[83] Christian Gieger,et al. Genetic Predictors of Fibrin D-Dimer Levels in Healthy Adults , 2011, Circulation.
[84] R. Hardison,et al. Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes , 2011, Proceedings of the National Academy of Sciences of the United States of America.
[85] J. Schlossmann,et al. Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation , 2011, Platelets.
[86] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[87] Wendy A. Wolf,et al. The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies , 2011, BMC Medical Genomics.
[88] S. Heath,et al. A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism , 2010, Journal of thrombosis and haemostasis : JTH.
[89] J. Krosl,et al. A mutant allele of the Swi/Snf member BAF250a determines the pool size of fetal liver hemopoietic stem cell populations. , 2010, Blood.
[90] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[91] L. Almasy,et al. C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. , 2010, Blood.
[92] Andrew D. Johnson,et al. Genome-wide meta-analyses identifies 7 loci associated with platelet aggregation in response to agonists , 2010, Nature genetics.
[93] J. Hansen,et al. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study , 2010, Journal of thrombosis and haemostasis : JTH.
[94] G. Blobel,et al. FOG1 requires NuRD to promote hematopoiesis and maintain lineage fidelity within the megakaryocytic-erythroid compartment. , 2009, Blood.
[95] J. Emmerich,et al. Association of influenza vaccination with reduced risk of venous thromboembolism , 2009, Thrombosis and Haemostasis.
[96] S. Heath,et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. , 2009, Blood.
[97] P. Libby,et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. , 2009, The New England journal of medicine.
[98] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[99] J. Hansen,et al. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study , 2008, Journal of thrombosis and haemostasis : JTH.
[100] P. Reitsma,et al. Gene variants associated with deep vein thrombosis. , 2008, Journal of the American Medical Association (JAMA).
[101] Jonghwan Kim,et al. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. , 2007, Molecular cell.
[102] T. Lumley,et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. , 2007, JAMA.
[103] M. Wilm,et al. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. , 2007, Blood.
[104] S. Hankinson,et al. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. , 2006, Cancer research.
[105] R. Shivdasani,et al. Mechanisms of thrombopoiesis , 2005, Journal of thrombosis and haemostasis : JTH.
[106] F. Rosendaal,et al. The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality , 2005, Annals of Internal Medicine.
[107] A. Reiner,et al. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. , 2004, JAMA.
[108] R. Holman,et al. Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.
[109] Scott Davis,et al. Implementation of the Women's Health Initiative study design. , 2003, Annals of epidemiology.
[110] C. Overall,et al. Identification, regulation and role of tissue inhibitor of metalloproteinases‐4 (TIMP‐4) in human platelets , 2002, British journal of pharmacology.
[111] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[112] Kiyoko Fukami,et al. Structure, regulation, and function of phospholipase C isozymes. , 2002, Journal of biochemistry.
[113] J. Korn,et al. The hcKrox gene family regulates multiple extracellular matrix genes. , 2001, Matrix biology : journal of the International Society for Matrix Biology.
[114] L. Almasy,et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. , 2000, American journal of human genetics.
[115] L. Almasy,et al. Genetic determinants of hemostasis phenotypes in Spanish families. , 2000, Circulation.
[116] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.
[117] W M O'Fallon,et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.
[118] JoAnn E. Manson,et al. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.
[119] K. Fukase,et al. Detection of UDP-D-Xylose:α-D-Xyloside α→3Xylosyltransferase Activity in Human Hepatoma Cell Line HepG2 , 1996 .
[120] K. Fukase,et al. Detection of UDP-D-xylose: alpha-D-xyloside alpha 1-->3xylosyltransferase activity in human hepatoma cell line HepG2. , 1996, Journal of Biochemistry (Tokyo).
[121] L. Fried,et al. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. , 1993, Annals of epidemiology.
[122] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[123] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[124] W. Kannel,et al. An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.
[125] W. Kannel,et al. The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.